RTN4 and Alzheimer disease: In agreement with the above-mentioned findings are studies by Xiao et al. conducted on APP transgenic mice, which have demonstrated that deletion of Nogo-A improves learning and memory deficits, simultaneously reducing AD-related pathology [6].